Omega Health downgraded by BofA Securities with a new price target
$OHI
Real Estate Investment Trusts
Real Estate
BofA Securities downgraded Omega Health from Buy to Neutral and set a new price target of $31.00 from $33.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/27/2025 | $41.00 → $39.00 | Overweight → Equal Weight | Wells Fargo |
| 12/9/2024 | $45.00 | Market Perform → Outperform | BMO Capital Markets |
| 10/31/2024 | $49.00 | Neutral → Outperform | Exane BNP Paribas |
| 10/18/2024 | $45.00 | Buy | Berenberg |
| 7/25/2024 | $34.00 → $35.00 | Outperform → Neutral | Mizuho |
| 3/22/2024 | $32.00 → $35.00 | Neutral → Buy | Citigroup |
| 2/26/2024 | $31.00 → $35.00 | Equal Weight → Overweight | Wells Fargo |
| 2/8/2024 | $30.00 | Underperform → Neutral | Exane BNP Paribas |
8-K - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Filer)
424B5 - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Filer)
8-K - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Filer)
Wells Fargo downgraded Omega Health from Overweight to Equal Weight and set a new price target of $39.00 from $41.00 previously
BMO Capital Markets upgraded Omega Health from Market Perform to Outperform and set a new price target of $45.00
Exane BNP Paribas upgraded Omega Health from Neutral to Outperform and set a new price target of $49.00
4 - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Issuer)
4 - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Issuer)
4 - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Issuer)